Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Susan Calcaterra to Narcotic Antagonists

This is a "connection" page, showing publications Susan Calcaterra has written about Narcotic Antagonists.

 
Connection Strength
 
 
 
2.277
 
  1. Calcaterra SL, Mann S, Grimm E, Keniston A, Saunders S. Perspectives of In-Hospital Intramuscular Naltrexone and Oral Medications for Alcohol Use Disorder: A Study of Addiction Clinicians and Hospitalized Patients. J Gen Intern Med. 2025 09; 40(12):2981-2988.
    View in: PubMed
    Score: 0.736
  2. Kee DP, Buyske JJ, Calcaterra SL. Things We Do for No Reason?: Avoiding naltrexone for alcohol use disorder in liver disease. J Hosp Med. 2025 Jul; 20(7):768-771.
    View in: PubMed
    Score: 0.734
  3. Scherbak Y, Wehrer M, Jacknin G, Nelson A, Calcaterra S. Bridging the Gap: Empowering Pharmacists in Inpatient Injectable Naltrexone and Hospital-Dispensed Methadone Process Development. J Am Coll Clin Pharm. 2026 Mar; 9(3):e70186.
    View in: PubMed
    Score: 0.200
  4. Lebin JA, Mitchell K, Trinkley KE, Calcaterra SL, Lun Z, Hensen C, Hoppe JA. Clinical Decision Support to Increase Naloxone Co-prescribing from the Inpatient Setting. J Gen Intern Med. 2026 01; 41(1):18-25.
    View in: PubMed
    Score: 0.192
  5. Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 10; 39(10):1023-1029.
    View in: PubMed
    Score: 0.127
  6. Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction. J Gen Intern Med. 2019 06; 34(6):1039-1042.
    View in: PubMed
    Score: 0.122
  7. Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA. Naloxone Administration in US Emergency Departments, 2000-2011. J Med Toxicol. 2016 06; 12(2):148-56.
    View in: PubMed
    Score: 0.102
  8. Ritvo AD, Calcaterra SL, Ritvo JI. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series. J Addict Med. 2021 May-Jun 01; 15(3):252-254.
    View in: PubMed
    Score: 0.036
  9. Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 10; 33(10):1646-1653.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)